Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 5
2013 8
2014 6
2015 3
2016 4
2017 4
2018 2
2019 16
2020 7
2021 13
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

58 results
Results by year
Filters applied: . Clear all
Page 1
Understanding type 1 diabetes: etiology and models.
Acharjee S, Ghosh B, Al-Dhubiab BE, Nair AB. Acharjee S, et al. Can J Diabetes. 2013 Aug;37(4):269-276. doi: 10.1016/j.jcjd.2013.05.001. Epub 2013 Aug 2. Can J Diabetes. 2013. PMID: 24070892 Review.
Crystallography, Molecular Modeling, and COX-2 Inhibition Studies on Indolizine Derivatives.
Venugopala KN, Chandrashekharappa S, Tratrat C, Deb PK, Nagdeve RD, Nayak SK, Morsy MA, Borah P, Mahomoodally FM, Mailavaram RP, Attimarad M, Aldhubiab BE, Sreeharsha N, Nair AB, Alwassil OI, Haroun M, Mohanlall V, Shinu P, Venugopala R, Kandeel M, Nandeshwarappa BP, Ibrahim YF. Venugopala KN, et al. Among authors: aldhubiab be. Molecules. 2021 Jun 10;26(12):3550. doi: 10.3390/molecules26123550. Molecules. 2021. PMID: 34200764 Free PMC article.
In vitro techniques to evaluate buccal films.
Nair AB, Kumria R, Harsha S, Attimarad M, Al-Dhubiab BE, Alhaider IA. Nair AB, et al. J Control Release. 2013 Feb 28;166(1):10-21. doi: 10.1016/j.jconrel.2012.11.019. Epub 2012 Dec 5. J Control Release. 2013. PMID: 23219961 Review.
Anti-tubercular activity and molecular docking studies of indolizine derivatives targeting mycobacterial InhA enzyme.
Venugopala KN, Chandrashekharappa S, Deb PK, Tratrat C, Pillay M, Chopra D, Al-Shar'i NA, Hourani W, Dahabiyeh LA, Borah P, Nagdeve RD, Nayak SK, Padmashali B, Morsy MA, Aldhubiab BE, Attimarad M, Nair AB, Sreeharsha N, Haroun M, Shashikanth S, Mohanlall V, Mailavaram R. Venugopala KN, et al. Among authors: aldhubiab be. J Enzyme Inhib Med Chem. 2021 Dec;36(1):1472-1487. doi: 10.1080/14756366.2021.1919889. J Enzyme Inhib Med Chem. 2021. PMID: 34210233 Free PMC article.
4-Aryl-1,4-Dihydropyridines as Potential Enoyl-Acyl Carrier Protein Reductase Inhibitors: Antitubercular Activity and Molecular Docking Study.
Venugopala KN, Deb PK, Pillay M, Chopra D, Chandrashekharappa S, Morsy MA, Aldhubiab BE, Attimarad M, Nair AB, Sreeharsha N, Kandeel M, Venugopala R, Mohanlall V. Venugopala KN, et al. Among authors: aldhubiab be. Curr Top Med Chem. 2021;21(4):295-306. doi: 10.2174/1568026620666201102121606. Curr Top Med Chem. 2021. PMID: 33138763
Graphene-based hybrid nanoparticle of doxorubicin for cancer chemotherapy.
SreeHarsha N, Maheshwari R, Al-Dhubiab BE, Tekade M, Sharma MC, Venugopala KN, Tekade RK, Alzahrani AM. SreeHarsha N, et al. Int J Nanomedicine. 2019 Sep 12;14:7419-7429. doi: 10.2147/IJN.S211224. eCollection 2019. Int J Nanomedicine. 2019. PMID: 31686814 Free PMC article.
58 results